Advanced or Metastatic Breast Cancer
Drug | Drug Name | Drug Description |
---|---|---|
DB01101 | Capecitabine | A nucleoside metabolic inhibitor indicated to treat different gastrointestinal, including pancreatic cancer, and breast cancer. |
DB00947 | Fulvestrant | An estrogen receptor antagonist used to treat HR+ breast cancer that may also be HER2-. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11666 | Buparlisib | 1 | Completed | 1 |
DB13051 | CH-5132799 | 1 | Active Not Recruiting | 1 |
DB12218 | Capivasertib | 1 | Active Not Recruiting | 1 |
DB12021 | Dinaciclib | 1 | Completed | 1 |
DB00947 | Fulvestrant | 1 | Active Not Recruiting | 2 |
DB01006 | Letrozole | 1 | Completed | 1 |
DB01229 | Paclitaxel | 1 | Completed | 1 |
DB17284 | Pelareorep | 1 | Completed | 1 |
DB09037 | Pembrolizumab | 1 | Completed | 1 |
DB11730 | Ribociclib | 1 | Completed | 1 |
DB00072 | Trastuzumab | 1 | Active Not Recruiting | 1 |
DB00928 | Azacitidine | 1 / 2 | Completed | 1 |
DB12218 | Capivasertib | 1 / 2 | Completed | 1 |
DB01229 | Paclitaxel | 1 / 2 | Completed | 2 |
DB06374 | Elacestrant | 2 | Not Yet Recruiting | 1 |
DB00947 | Fulvestrant | 2 | Terminated | 1 |
DB15257 | Milademetan | 2 | Terminated | 1 |
DB11793 | Niraparib | 2 | Not Yet Recruiting | 1 |
DB17391 | Trastuzumab vedotin | 2 | Recruiting | 1 |
DB01101 | Capecitabine | 3 | Active Not Recruiting | 1 |
DB01590 | Everolimus | 3 | Recruiting | 1 |
DB00990 | Exemestane | 3 | Recruiting | 1 |
DB00947 | Fulvestrant | 3 | Recruiting | 1 |
DB01229 | Paclitaxel | 3 | Active Not Recruiting | 1 |
DB14962 | Trastuzumab deruxtecan | 3 | Active Not Recruiting | 1 |